Table of Contents
Lung Cancer International
Volume 2015 (2015), Article ID 204826, 6 pages
http://dx.doi.org/10.1155/2015/204826
Research Article

Effect of Perioperative β-Blockers on Pulmonary Complications among Patients with Chronic Obstructive Pulmonary Disease Undergoing Lung Resection Surgery

1Long Island Pulmonary and Sleep Associates, 200 North Village Avenues, Suite 300, Rockville Centre, NY 11750-5294, USA
2Primary Research Institution, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021-9809, USA

Received 28 May 2015; Revised 13 August 2015; Accepted 19 August 2015

Academic Editor: Giovanni Luca Ceresoli

Copyright © 2015 A. Kamath et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Cancer Society, Cancer Facts & Figures 2012, Secondary American Cancer Society, 2012, http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2012.
  2. L. A. Fleisher, J. A. Beckman, K. A. Brown et al., “ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery,” Circulation, vol. 116, no. 17, 2007. View at Google Scholar
  3. A. D. Auerbach and L. Goldman, “β-blockers and reduction of cardiac events in noncardiac surgery: scientific review,” The Journal of the American Medical Association, vol. 287, no. 11, pp. 1435–1444, 2002. View at Google Scholar · View at Scopus
  4. A. S. Blaustein, “Preoperative and perioperative management of cardiac patients undergoing noncardiac surgery,” Cardiology Clinics, vol. 13, no. 2, pp. 149–161, 1995. View at Google Scholar · View at Scopus
  5. P. J. Devereaux, W. S. Beattie, P. T.-L. Choi et al., “How strong is the evidence for the use of perioperative β blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials,” British Medical Journal, vol. 331, no. 7512, pp. 313–316, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Yang, K. Raymer, R. Butler, J. Parlow, and R. Roberts, “The effects of perioperative β-blockade: results of the metoprolol after vascular surgery (MaVS) study, a randomized controlled trial,” American Heart Journal, vol. 152, no. 5, pp. 983–990, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. P. K. Lindenauer, P. Pekow, K. Wang, D. K. Mamidi, B. Gutierrez, and E. M. Benjamin, “Perioperative beta-blocker therapy and mortality after major noncardiac surgery,” The New England Journal of Medicine, vol. 353, no. 4, pp. 349–361, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. D. T. Mangano, E. L. Layug, A. Wallace, and I. Tateo, “Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery,” The New England Journal of Medicine, vol. 335, no. 23, pp. 1713–1720, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. M. R. Andrus, K. P. Holloway, and D. B. Clark, “Use of beta-blockers in patients with COPD,” The Annals of Pharmacotherapy, vol. 38, no. 1, pp. 142–145, 2004. View at Google Scholar · View at Scopus
  10. S. R. Salpeter, T. M. Ormiston, E. E. Salpeter, P. J. Poole, and C. J. Cates, “Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis,” Respiratory Medicine, vol. 97, no. 10, pp. 1094–1101, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. D. H. Au, C. L. Bryson, V. S. Fan et al., “Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease,” American Journal of Medicine, vol. 117, no. 12, pp. 925–931, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Çamsari, S. Arikan, C. Avan et al., “Metoprolol, a beta-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary disease,” Heart and Vessels, vol. 18, no. 4, pp. 188–192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Almagro, E. Calbo, A. Ochoa de Echagüen et al., “Mortality after hospitalization for COPD,” Chest, vol. 121, no. 5, pp. 1441–1448, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. N. R. Anthonisen, M. A. Skeans, R. A. Wise, J. Manfreda, R. E. Kanner, and J. E. Connett, “The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial,” Annals of Internal Medicine, vol. 142, no. 4, pp. 233–239, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. L. H. Kuller, J. K. Ockene, M. Townsend, W. Browner, E. Meilahn, and D. N. Wentworth, “The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial,” American Review of Respiratory Disease, vol. 140, no. 3, part 2, pp. S76–S81, 1989. View at Publisher · View at Google Scholar · View at Scopus
  16. M. S. Tockman and G. W. Comstock, “Respiratory risk factors and mortality: longitudinal studies in Washington County, Maryland,” American Review of Respiratory Disease, vol. 140, no. 3, part 2, pp. S56–S63, 1989. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Vilkman, T. Keistinen, T. Tuuponen, and S.-L. Kivelä, “Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospital,” Respiration, vol. 64, no. 4, pp. 281–284, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. B. R. Celli, W. MacNee, and A. E. T. Force, “Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper,” European Respiratory Journal, vol. 23, no. 6, pp. 932–946, 2004. View at Google Scholar
  19. T. Okita, M. Uji, T. Shinjo et al., “Use of landiolol hydrochloride for the prevention of atrial fibrillation after lung resection,” Japanese Journal of Anesthesiology, vol. 57, no. 8, pp. 953–958, 2008. View at Google Scholar · View at Scopus
  20. D. Poldermans, E. Boersma, J. J. Bax et al., “The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery,” The New England Journal of Medicine, vol. 341, no. 24, pp. 1789–1794, 1999. View at Publisher · View at Google Scholar
  21. Erasmus Medical Centre, Report on the 2012 Follow-Up Investigation of Possible Breaches of Academic Integrity, 2012, https://cardiobrief.files.wordpress.com/2012/10/integrity-report-2012-10-english-translation.pdf.
  22. G. D. Cole and D. P. Francis, “Perioperative β blockade: guidelines do not reflect the problems with the evidence from the DECREASE trials,” The British Medical Journal, vol. 349, Article ID g5210, 2014. View at Publisher · View at Google Scholar
  23. P. J. Devereaux, H. Yang, S. Yusuf et al., “Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial,” The Lancet, vol. 371, no. 9627, pp. 1839–1847, 2008. View at Publisher · View at Google Scholar
  24. D. N. Wijeysundera, D. Duncan, C. Nkonde-Price et al., “Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American college of cardiology/American heart association task force on practice guidelines,” Journal of the American College of Cardiology, vol. 64, no. 22, pp. 2406–2425, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Leo, N. Venissac, D. Pop et al., “Postoperative exacerbation of chronic obstructive pulmonary disease. Does it exist?” European Journal of Cardio-Thoracic Surgery, vol. 33, no. 3, pp. 424–429, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. H. J. van der Woude, J. Zaagsma, D. S. Postma, T. H. Winter, M. van Hulst, and R. Aalbers, “Detrimental effects of beta-blockers in COPD: a concern for nonselective β-blockers,” Chest, vol. 127, no. 3, pp. 818–824, 2005. View at Publisher · View at Google Scholar
  27. Y. R. B. M. van Gestel, S. E. Hoeks, D. D. Sin et al., “Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 7, pp. 695–700, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. T. Dransfield, S. M. Rowe, J. E. Johnson, W. C. Bailey, and L. B. Gerald, “Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD,” Thorax, vol. 63, no. 4, pp. 301–305, 2008. View at Publisher · View at Google Scholar · View at Scopus